Efficacy of L-lisin aescinat® application for intracranial hypertension correction in injured persons with severe cranio-cerebral trauma

Abstract

Materials of open randomized study of L-lizin escinat® efficacy are presented. The results of clinical study showed, that L-lizin escinat® used in dose 10 ml twice a day intravenously promotes statistically decreasing of expressed intracranial hypertension in injured persons with severe cranio-cerebral trauma.